Vol 55, No 3 (2024)
Clinical vignette
Published online: 2024-06-24
Hyperleukocytosis and leukostasis as fatal consequences of childhood acute myeloid leukemia
DOI: 10.5603/ahp.99242
Acta Haematol Pol 2024;55(3):174-176.
Abstract
< p > < /p >
Keywords: acute myeloid leukemiahyperleukocytosisleukostasis
References
- Morais RV, Souza MV, Silva KA, et al. Epidemiological evaluation and survival of children with acute myeloid leukemia. J Pediatr (Rio J). 2021; 97(2): 204–210.
- Macaron W, Sargsyan Z, Short NJ. Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leuk Lymphoma. 2022; 63(8): 1780–1791.
- Kittivisuit S, Jongthitinon N, Sripornsawan P, et al. Hyperleukocytosis in childhood acute leukemia: early complications and survival outcomes. Cancers (Basel). 2023; 15(12): 3072.
- Bewersdorf JP, Zeidan AM. Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments? Cells. 2020; 9(10): 2310.
- Spring J, Munshi L. Oncologic emergencies: traditional and contemporary. Crit Care Clin. 2021; 37(1): 85–103.
- Christakopoulos G, Walker K, Wang L, et al. Clinical features and cytoreduction therapy in children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Blood. 2021; 138(Supplement 1): 2295–2295.
